AI assistant
IGC Pharma, Inc. — Director's Dealing 2021
Dec 23, 2021
34705_dirs_2021-12-23_b7b12e12-e0b3-48f9-9acd-023c8435ecdd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2021-12-20
Reporting Person: MUKUNDA RAM (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-20 | Common Stock | A | 0 | $0.0 | Acquired | 2174760 | Direct |
| 2021-12-20 | Common Stock | A | 0 | $0.0 | Acquired | 727417 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-20 | Restricted Stock Units | $0.0 | A | 1000000 | Acquired | 2024-04-01 | Common Stock (1000000) | Direct |
| 2021-12-20 | Restricted Stock Units | $0.0 | A | 3200000 | Acquired | Common Stock (3200000) | Direct | |
| 2021-12-20 | Restricted Stock Units | $0.0 | A | 50000 | Acquired | 2024-04-01 | Common Stock (50000) | Indirect |
Footnotes
F1: RSUs subject to vesting equally over three years starting on March 31, 2022.
F2: Corrects a previous Section 16 May 14, 2021, filing, which overstated the ownership of non-derivative securities by 1,000,000 shares.
F3: RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs do not have an exercisable or expiration date. The RSUs vest when milestones are achieved.
F4: RSUs subject to vesting equally over three years starting on March 31, 2022.
F5: Corrects a previous Section 16 May 14, 2021, filing, which overstated the ownership of non-derivative securities by 50,000 shares